Chemicals Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Chemicals Press Releases.

Press releases published on September 24, 2026

Sep. 24, 2026

Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis

Indeterminate GlobeNewswire

Sep. 24, 2026

Elicio Therapeutics Announces Late-Breaking Phase 2 AMPLIFY-7P Data Selected for Proffered Paper Oral Presentation at ESMO Congress 2026

Indeterminate GlobeNewswire

Sep. 24, 2026

Precision Neuroscience Closes Oversubscribed $250M Series D Led by Pershing Square Inc., the Ackman Oxman Institute, and a Leading Life Sciences Investment Fund

Indeterminate GlobeNewswire

Sep. 24, 2026

EBANX advances emerging market infrastructure with Pakistan expansion in motion and native Apple Pay decryption

Indeterminate GlobeNewswire

Sep. 24, 2026

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces Upcoming Late-Breaking Presentation of MAR001 Clinical Data at the American Heart Association Scientific Sessions 2026

Indeterminate GlobeNewswire

Sep. 24, 2026

Nuvectis Announces NXP200 Granted Breakthrough Therapy Designation in China for BRAF V600-Mutant, Recurrent or Progressive, High-Grade Glioma

Indeterminate GlobeNewswire

Sep. 24, 2026

Quantum Biopharma Licensee Unbuzzd Wellness to Advance Clinically Validated Alcohol Metabolism Accelerant After Appointing Zappy as CEO

Indeterminate GlobeNewswire

Sep. 24, 2026

New Preclinical Data Further Support Potential for Tvardi’s STAT3 Inhibitors in Ulcerative Colitis (UC)

Indeterminate GlobeNewswire

Sep. 24, 2026

ZenaTech’s ZenaDrone Advances Defense-Focused Quantum Navigation System for GPS-Denied Operations to Drone Testing Phase

Indeterminate GlobeNewswire

Sep. 24, 2026

Collective Metals Announces Appointment of Curtis Riou to its Board of Directors

Indeterminate GlobeNewswire

Sep. 24, 2026

HTVRONT Makes PRINTING United Expo Debut with Expanded Personalization Portfolio

Indeterminate GlobeNewswire

Sep. 24, 2026

Annexon to Present Patient Baseline Characteristics from Vonaprument Phase 3 ARCHER II Pivotal Trial for Geographic Atrophy at The Retina Society 59th Annual Scientific Meeting

Indeterminate GlobeNewswire

Sep. 24, 2026

Trident Regains Compliance with Nasdaq Minimum Market Value of Listed Securities Requirement

Indeterminate GlobeNewswire

Sep. 24, 2026

La Mancha Investments S. à r. l. to File Early Warning Report

Indeterminate GlobeNewswire

Sep. 24, 2026

Dillard’s Offers Exclusive Southern Living Christmas Cookbook

Indeterminate GlobeNewswire

Sep. 24, 2026

Sofwave Receives NMPA Approval in Mainland China

Indeterminate GlobeNewswire

Sep. 24, 2026

3 E Network Partners with HashBeaver to Expand Web3 Distribution of Finnish Green AI Compute

Indeterminate GlobeNewswire

Sep. 24, 2026

Nexentis: MitoCareX Strengthens Its Computational Drug Discovery Capabilities with Appointment of Prof. Dan T. Major to Scientific Advisory Board

Indeterminate GlobeNewswire

Sep. 24, 2026

Sky Quarry Restarts Nevada's Only Crude Oil Refinery

Indeterminate GlobeNewswire

Sep. 24, 2026

JM Search Releases 2026 CEO Compensation & Insights Study

Indeterminate GlobeNewswire